Testing blood and body markers in lung and chest cancers
Part of Cancer, Lungs & breathing clinical trials.
This study looks at “biomarkers,” which are measurable signs in the body (often in blood or samples), in people with lung or other chest cancers. It may help researchers better understand these cancers and improve how they’re diagnosed or tracked.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Have a known or likely cancer in the chest (like the lungs) that needs a biopsy or surgical removal
- Be able to undergo surgery for the biopsy or excision
- Not have diabetes that is poorly controlled (your diabetes must be well managed)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for new “epigenetic” signals in blood (signals about how genes are turned on/off) to help detect lung cancer early. You might be able to join if you are being evaluated for possible lung cancer or have small, unclear spots on a lung CT scan.
This study is testing whether certain markers in your blood or tissue can help find lung cancer early. It is for people who have lung cancer that can be removed by surgery and haven't had treatment yet.
This study is testing a new way to help find lung cancer earlier by combining imaging (like CT scans) with a blood test that looks at DNA changes. If you have lung cancer and haven't started treatment yet, participating may help improve future detection methods.
This trial studies blood and tissue samples from people with COPD, IPF, or lung cancer to find markers that can help diagnose and predict these conditions. It aims to discover why some lung diseases progress to cancer.
This study looks for specific genetic markers of lung cancer by testing tissue taken from a lung mass. It may help doctors detect and better understand lung cancer based on genetic clues.
This study uses a blood test to look for tiny genetic markers (miRNA and DNA methylation) that may help detect lung cancer early. If you have a lung nodule or mass found on a CT scan and haven't had treatment yet, you may be able to join.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.